Saturday, March 21, 2026

How Celltrion’s Herceptin Biosimilar Herzuma Achieved 74% Market Share in Japan: A Game Changer for Cancer Treatment

Celltrion's Herzuma biosimilar captures 74% of Japan's trastuzumab market, enhancing patient access and leveraging favorable policies.

NOW A SERVANT?: South Korea Was A Puppet State, Refusing To Condemn North Korea’s Human Rights MASSACRE

South Korea rejoined as a co-sponsor of a UN resolution on North Korean human rights, condemning abuses and seeking accountability.

Unlocking the Future of Healthcare: How Adaptive Clinical Trials Can Transform Regenerative Medicine in Asia

The article discusses South Korea's efforts to ease regulations on regenerative medicine to improve patient access while addressing significant challenges.

Tag: transgender rights

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.